Renaissance BioScience Corp., a global leader in yeast bioengineering, announced the appointment of Dr. James Tansey to its Board of Directors. Dr. Tansey is a serial entrepreneur, research academic and business leader with extensive experience in life sciences, technology commercialization, fundraising and corporate governance. He is a Professor at the University of British Columbia's Sauder School of Business and was previously a faculty member at Oxford University's Saïd Business School. Dr. Tansey is a member of the founding team at Gemina Labs, where he supports fundraising, business development and shareholder strategy. He also serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd., and is a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund.
Dr. Tansey's appointment is significant as Renaissance focuses on technology platforms of yeast-produced RNA and yeast-derived virus-like particles (VLPs), with initial applications in crop protection and future applications in animal and human health. His expertise in impact investing and environmental sustainability aligns with the company's mission to address environmental challenges through innovative biotechnology. Maurice Boucher, Renaissance Co-Founder and Executive Chairman, stated: "James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow. James has consistently focused on 'Impact Investing' and environmental protection and sustainability throughout his exceptional career, which fits well with the positive environmental impact of Renaissance's technology platforms."
Dr. Tansey commented on his new role: "Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value." Dr. John Husnik, Renaissance Co-Founder, Director and CSO, emphasized the strategic value of the appointment: "We are excited to welcome Dr. Tansey to our board. His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms."
Renaissance BioScience Corp., based in Vancouver, Canada, is a global-leading yeast bioengineering company developing innovative, market-ready, functional microorganisms that provide cost-effective solutions to address environmental and industrial challenges in agriculture, food, nutrition, and animal and human health. The addition of Dr. Tansey is expected to bolster the company's governance and strategic direction as it continues to commercialize its biotechnology platforms globally.
